Catalytic Stereoconvergent Synthesis of Homochiral β-CF3, β-SCF3, and β-OCF3 Benzylic Alcohols
- PMID: 36217345
- PMCID: PMC9542724
- DOI: 10.1021/acsorginorgau.2c00019
Catalytic Stereoconvergent Synthesis of Homochiral β-CF3, β-SCF3, and β-OCF3 Benzylic Alcohols
Abstract
We describe an efficient catalytic strategy for enantio- and diastereoselective synthesis of homochiral β-CF3, β-SCF3, and β-OCF3 benzylic alcohols. The approach is based on dynamic kinetic resolution (DKR) with Noyori-Ikariya asymmetric transfer hydrogenation leading to simultaneous construction of two contiguous stereogenic centers with up to 99.9% ee, up to 99.9:0.1 dr, and up to 99% isolated yield. The origin of the stereoselectivity and racemization mechanism of DKR is rationalized by density functional theory calculations. Applicability of the previously inaccessible chiral fluorinated alcohols obtained by this method in two directions is further demonstrated: As building blocks for pharmaceuticals, illustrated by the synthesis of heat shock protein 90 inhibitor with in vitro anticancer activity, and in particular, needle-shaped crystals of representative stereopure products that exhibit either elastic or plastic flexibility, which opens the door to functional materials based on mechanically responsive chiral molecular crystals.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures




Similar articles
-
Asymmetric Transfer Hydrogenation of α-Substituted-β-Keto Carbonitriles via Dynamic Kinetic Resolution.J Am Chem Soc. 2021 Feb 17;143(6):2477-2483. doi: 10.1021/jacs.0c13273. Epub 2021 Feb 2. J Am Chem Soc. 2021. PMID: 33529522
-
Escaping from Flatland: Stereoconvergent Synthesis of Three-Dimensional Scaffolds via Ruthenium(II)-Catalyzed Noyori-Ikariya Transfer Hydrogenation.Chemistry. 2021 Jan 4;27(1):39-53. doi: 10.1002/chem.202002779. Epub 2020 Oct 22. Chemistry. 2021. PMID: 32691439 Review.
-
Enantioselective and Diastereoselective Construction of Chiral Amino Alcohols by Iridium-f-Amphox-Catalyzed Asymmetric Hydrogenation via Dynamic Kinetic Resolution.Org Lett. 2017 May 19;19(10):2548-2551. doi: 10.1021/acs.orglett.7b00844. Epub 2017 Apr 27. Org Lett. 2017. PMID: 28448152
-
Asymmetric Transfer Hydrogenation of Arylidene-Substituted Chromanones and Tetralones Catalyzed by Noyori-Ikariya Ru(II) Complexes: One-Pot Reduction of C═C and C═O bonds.J Org Chem. 2021 Mar 19;86(6):4849-4858. doi: 10.1021/acs.joc.0c02981. Epub 2021 Mar 8. J Org Chem. 2021. PMID: 33683900
-
Ketoreductase Catalyzed (Dynamic) Kinetic Resolution for Biomanufacturing of Chiral Chemicals.Front Bioeng Biotechnol. 2022 Jun 30;10:929784. doi: 10.3389/fbioe.2022.929784. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35845398 Free PMC article. Review.
Cited by
-
Noyori-Ikariya Asymmetric Transfer Hydrogenation of Prochiral α‑CF3 and α‑SF5 Ketones.ACS Org Inorg Au. 2025 Jun 17;5(4):269-274. doi: 10.1021/acsorginorgau.5c00038. eCollection 2025 Aug 6. ACS Org Inorg Au. 2025. PMID: 40786877 Free PMC article.
-
(S)-2-[(S)-2,2,2-Tri-fluoro-1-hy-droxy-eth-yl]-1-tetra-lone.IUCrdata. 2023 Jan 6;8(Pt 1):x221209. doi: 10.1107/S2414314622012093. eCollection 2023 Jan. IUCrdata. 2023. PMID: 36794051 Free PMC article.
-
New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.J Med Chem. 2024 Aug 8;67(15):12984-13018. doi: 10.1021/acs.jmedchem.4c00932. Epub 2024 Jul 23. J Med Chem. 2024. PMID: 39042910 Free PMC article.
-
(1S,2S)-2-[(S)-2,2,2-Tri-fluoro-1-hy-droxy-eth-yl]-1-tetra-lol.IUCrdata. 2023 Mar 15;8(Pt 3):x230217. doi: 10.1107/S2414314623002171. eCollection 2023 Mar. IUCrdata. 2023. PMID: 37180347 Free PMC article.
-
Catalytic Asymmetric Transfer Hydrogenation of β,γ-Unsaturated α-Diketones.J Am Chem Soc. 2024 Dec 11;146(49):33543-33560. doi: 10.1021/jacs.4c11070. Epub 2024 Nov 27. J Am Chem Soc. 2024. PMID: 39604061 Free PMC article.
References
-
- Han J.; Remete A. M.; Dobson L. S.; Kiss L.; Izawa K.; Moriwaki H.; Soloshonok V. A.; O’Hagan D. Next Generation Organofluorine Containing Blockbuster Drugs.. J. Fluorine Chem. 2020, 239, 109639.10.1016/j.jfluchem.2020.109639. - DOI
-
- Mei H.; Remete A. M.; Zou Y.; Moriwaki H.; Fustero S.; Kiss L.; Soloshonok V. A.; Han J. Fluorine-Containing Drugs Approved by the FDA in 2019.. Chin. Chem. Lett. 2020, 31, 2401–2413. 10.1016/j.cclet.2020.03.050. - DOI
LinkOut - more resources
Full Text Sources
Research Materials